Lukaku set for medical ahead of Fenerbahce transfer on August 12
Yahoo Sports • 1 min read • Latest: Aug 11, 2026, 8:05 PM
Last updated Aug 11, 2026

Romelu Lukaku is scheduled for intensive medical tests on August 12 as part of his transfer to Fenerbahce. Napoli will share a fee of €6 million plus bonuses with Chelsea, with approximately €2.45 million going to Chelsea as part of the agreement. Lukaku’s transfer follows a challenging season at Napoli, where he struggled with a serious muscular injury and only made seven appearances. Completing the medical tests is crucial for the transfer to move forward, ensuring club officials can confirm his fitness.
- •Lukaku undergoes medical tests in Belgium on August 12.
- •Napoli shares €6 million fee with Chelsea, about €2.45 million owed.
- •Lukaku managed only one goal in seven appearances last season.
- •Fenerbahce's total payment may reach €10 million with add-ons.
- •Medical tests are essential for confirming Lukaku's fitness.
- 8:05 PMYahoo Sports — Lukaku must have intensive Fenerbahce medical, Napoli share €6m fee with Chelsea
"Romelu Lukaku is set for intensive medical tests on Wednesday August 12 before flying out for his Fenerbahce transfer, while Napoli must share the €6m plus bonus fee with Chelsea.RIJEKA, CROATIA –...
Sources
External linksOriginal reporting and copyright belong to the linked sources. SportsNewsReport.com aggregates and links — it does not republish full articles.
Related Stories
Last 14 days
EPL•Aug 11, 2026, 8:55 PMChelsea reject chance to sign Myles Lewis-Skelly
EPL•Aug 11, 2026, 8:27 PMChelsea reach transfer decision after Mykhailo Mudryk makes Xabi Alonso debut
EPL•Aug 11, 2026, 8:05 PMIt's official, Liverpool have just signed their next Jordan Henderson
EPL•Aug 11, 2026, 7:35 PMChelsea Urged To Launch A Move For This Tottenham Hotspur Full-Back: Should Alonso Snap Him Up?
EPL•Aug 11, 2026, 6:50 PMReport: Manchester City eye Chelsea star as Rodri successor
EPL•Aug 11, 2026, 6:05 PMManchester City Are Showing Interest In This Barcelona Youngster: One For The Future?
